Bioblast Pharma Ltd. (ORPN) rose 6.48% or 0.07 to $1.15. It is approximately 11822 shares traded, which is 51.41% compare to the average total volume 22995. The market cap of ORPN is $3.86 million. The year to date change is 33.51%. The 52 week price range is from $0.77 to $3.75. Price of ORPN have changed -1.71% during last week. It have changed 48.62% over last month, -11.54% over last 3 months, -0.86% over last 6 months and -59.07% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 1.08. It is -6.09% below current price. The 200-day Moving Averages for ORPN is 1.48. It is 28.70% above current price. The 52-week High is 3.75. It is 226.09% from the current price. The 52-week Low is 0.77. It is -33.04% from current price.
There are some statistics of ORPN. It is has market cap $3.86 million. The share outstanding is 3.36 million. The average volume is 22995. The percent of top 15 Institution holding is 3.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -106.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -92.38%.